BeiGene
BGNE
#973
Rank
โ‚ฌ18.73 B
Marketcap
171,23ย โ‚ฌ
Share price
0.49%
Change (1 day)
19.39%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (BGNE)

Market cap: โ‚ฌ18.73 Billion

As of March 2025 BeiGene has a market cap of โ‚ฌ18.73 Billion. This makes BeiGene the world's 973th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ18.73 B-1.48%
2024โ‚ฌ19.01 B6.07%
2023โ‚ฌ17.92 B-18.03%
2022โ‚ฌ21.87 B-9.89%
2021โ‚ฌ24.27 B24.24%
2020โ‚ฌ19.53 B112.73%
2019โ‚ฌ9.18 B26.06%
2018โ‚ฌ7.28 B96.42%
2017โ‚ฌ3.70 B223.87%
2016โ‚ฌ1.14 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ19.37 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.08 B-94.22%๐Ÿ‡บ๐Ÿ‡ธ USA